Huron Consulting Group (HURN) Scheduled to Post Quarterly Earnings on Tuesday

Huron Consulting Group (NASDAQ:HURN) will post its quarterly earnings results after the market closes on Tuesday, April 30th. Analysts expect Huron Consulting Group to post earnings of $0.88 per share for the quarter. Huron Consulting Group has set its FY24 guidance at $5.35-5.95 EPS and its FY 2024 guidance at 5.350-5.950 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.

Huron Consulting Group (NASDAQ:HURN) last announced its quarterly earnings results on Tuesday, February 27th. The business services provider reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.12 by $0.17. The company had revenue of $339.23 million for the quarter, compared to the consensus estimate of $341.71 million. Huron Consulting Group had a return on equity of 17.77% and a net margin of 4.47%. The firm’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same period last year, the firm earned $1.12 EPS. On average, analysts expect Huron Consulting Group to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Huron Consulting Group Stock Performance

Shares of HURN stock opened at $93.20 on Tuesday. The business has a 50-day simple moving average of $97.58 and a 200-day simple moving average of $101.04. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.61. The stock has a market cap of $1.72 billion, a PE ratio of 29.13 and a beta of 0.58. Huron Consulting Group has a 52-week low of $70.66 and a 52-week high of $113.31.

Insider Buying and Selling at Huron Consulting Group

In other news, Director John Mccartney sold 300 shares of the business’s stock in a transaction dated Friday, March 1st. The shares were sold at an average price of $98.13, for a total transaction of $29,439.00. Following the completion of the sale, the director now owns 56,919 shares of the company’s stock, valued at $5,585,461.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Huron Consulting Group news, Director John Mccartney sold 300 shares of the firm’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $98.13, for a total value of $29,439.00. Following the transaction, the director now directly owns 56,919 shares of the company’s stock, valued at approximately $5,585,461.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director James H. Roth sold 6,804 shares of the business’s stock in a transaction dated Monday, March 25th. The shares were sold at an average price of $95.00, for a total transaction of $646,380.00. Following the transaction, the director now directly owns 62,825 shares in the company, valued at approximately $5,968,375. The disclosure for this sale can be found here. Over the last three months, insiders have sold 42,080 shares of company stock valued at $4,146,076. Company insiders own 2.20% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on HURN shares. Barrington Research lifted their target price on shares of Huron Consulting Group from $128.00 to $133.00 and gave the company an “outperform” rating in a report on Wednesday, March 6th. StockNews.com cut shares of Huron Consulting Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 28th.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children's and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.